Ani Kardashian, MD

Dr. Ani Kardashian is an Assistant Professor of Medicine in the Division of Gastroenterology and Liver Diseases at the Keck School of Medicine at the University of Southern California. She is a transplant hepatologist who specializes in caring for patients with fatty liver, cirrhosis, and patients who undergo liver transplantation. Her research interests include understanding the social factors that contribute to the development and management of chronic liver diseases, viral hepatitis and nonalcoholic fatty liver disease, and liver disease in HIV infection.

Dr. Kardashian received her MD from the University of California, San Francisco and completed Internal Medicine residency at the University of California, San Francisco. She then completed fellowships in Gastroenterology at University of California, Los Angeles and in Transplant Hepatology from the University of California, San Francisco. Dr. Kardashian is a member of the American College of Gastroenterology, American Gastroenterological Association, and American Association for the Study of Liver Diseases. She is board certified by the American Board of Internal Medicine in internal medicine, gastroenterology, and transplant hepatology.

• University of Southern California: Mentored Career Development in Clinical and Translational Science Program (KL2), 2022-2025
• International Liver Congress/EASL: Young Investigator Bursary Award for Outstanding Abstract, 2021
• Department of Medicine, University of California San Francisco: Clinical Fellow of the Year, 2020
• American Society of Transplantation: Women’s Health Community of Practice Outstanding Abstract Award, 2020
• American Association for the Study of Liver Diseases: Advanced/Transplant Hepatology Award (grant), 2019-2021
• American College of Gastroenterology: Young Physicians Leadership Program, 2018-2019
• HIV and Liver Disease Seventh Biennial Meeting: Young Investigator Award, 2018
• American Association for the Study of Liver Diseases: Resident/Fellow Ambassador Award, 2017-2018
• HIV and Liver Disease Sixth Biennial Meeting: Young Investigator Award, 2016
• American Association for the Study of Liver Diseases: Emerging Liver Scholar, 2015
• University of California San Francisco School of Medicine: Clinical and Translational Research Award, 2015
• University of California San Francisco School of Medicine: Alpha Omega Alpha, 2013
• Stanford University: Graduated with Distinction, 2008
• Stanford University: Phi Beta Kappa, 2007

• Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease Hepatol Commun. 2024 May 01; 8(5). . View in PubMed
• Microbial Translocation and Gut Damage Are Associated With an Elevated Fast Score in Women Living With and Without HIV Open Forum Infect Dis. 2024 May; 11(5):ofae187. . View in PubMed
• The effects of food insecurity on hepatic steatosis and fibrosis in people with HIV Clin Gastroenterol Hepatol. 2024 Apr 05. . View in PubMed
• Increasing pharmacoequity for people with cirrhosis Clin Liver Dis (Hoboken). 2024 Jan-Jun; 23(1):e0203. . View in PubMed
• Quantifying the Negative Impact of Fast-food Consumption on Liver Steatosis Among United States Adults With Diabetes and ObesityClin Gastroenterol Hepatol. 2023 11; 21(12):3176-3178. e3. . View in PubMed
• The key role of hepatology providers in optimizing reproductive care in patients with liver disease: A call to action Hepatology. 2023 07 01; 78(1):363-367. . View in PubMed
• Parental leave, childcare policies, and workplace bias for hepatology professionals: A national survey Hepatol Commun. 2023 09 01; 7(9). . View in PubMed
• Health disparities in chronic liver disease Hepatology. 2023 04 01; 77(4):1382-1403. . View in PubMed
• Food Insecurity is Associated With Mortality Among US. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis. Clin Gastroenterol Hepatol. 2022 Dec; 20(12):2790-2799. e4. . View in PubMed
• Gender and Other Factors Associated with Endoscopy Volume Among US. Gastroenterology Fellows. Clin Gastroenterol Hepatol. 2022 Dec; 20(12):2911-2914. e4. . View in PubMed
• Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a US. population-based study. Aliment Pharmacol Ther. 2022 Nov; 56(9):1383-1393. . View in PubMed
• Achieving health equity in liver disease pharmacotherapy Nat Rev Gastroenterol Hepatol. 2022 08; 19(8):489-490. . View in PubMed
• Plasma metabolomic analysis indicates flavonoids and sorbic acid are associated with incident diabetes: A nested case-control study among Women’s Interagency HIV Study participants PLoS One. 2022; 17(7):e0271207. . View in PubMed
• The role of endoscopic ultrasound in evaluating patients with bile duct dilation of unclear etiology J Dig Dis. 2021 Oct; 22(10):597-603. . View in PubMed
• Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates Hepatology. 2021 03; 73(3):1132-1139. . View in PubMed
• Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action Hepatology. 2021 02; 73(2):811-820. . View in PubMed
• Identifying Quality Gaps in Preventive Care for Outpatients With Cirrhosis Within a Large, Academic Health Care System Hepatol Commun. 2020 Dec; 4(12):1802-1811. . View in PubMed
• Liver Transplantation Outcomes in a US. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020 12; 72(6):2014-2028. . View in PubMed
• Reply Hepatology. 2020 10; 72(4):1500. . View in PubMed
• The Pathogenesis of Liver Disease in People Living With Human Immunodeficiency Virus: The Emerging Role of the Microbiome Clin Liver Dis (Hoboken). 2020 Jan; 15(1):46-51. . View in PubMed
• NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities Curr Hepatol Rep. 2019 Dec; 18(4):425-432. . View in PubMed
• High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus-Coinfected Women Open Forum Infect Dis. 2019 Jul; 6(7):ofz281. . View in PubMed
• Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist Liver Res. 2019 Jun; 3(2):118-127. . View in PubMed
• Empowering early career female gastroenterologists and hepatologists Nat Rev Gastroenterol Hepatol. 2019 11; 16(11):644-645. . View in PubMed
• Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing Therapy Clin Infect Dis. 2019 05 02; 68(10):1784-1787. . View in PubMed
• Hemobilia: Etiology, diagnosis, and treatment? . Liver Res. 2018 Dec; 2(4):200-208.. View in PubMed
• Use of hepatitis C-positive grafts in hepatitis C-negative liver transplant recipients is cost effective Clin Transplant. 2018 10; 32(10):e13383. . View in PubMed
• Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list Liver Int. 2018 03; 38(3):553-563. . View in PubMed
• Sex differences in the association of HIV infection with hepatic steatosis AIDS. 2017 01 28; 31(3):365-373. . View in PubMed
• Hepatitis C virus-HIV-coinfected patients and liver transplantation Curr Opin Organ Transplant. 2015 Jun; 20(3):276-85. . View in PubMed
• A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk Breast Cancer Res Treat. 2013 Nov; 142(2):389-98. . View in PubMed
• Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations Fam Cancer. 2012 Sep; 11(3):429-39. . View in PubMed
• A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome Hered Cancer Clin Pract. 2012 Apr 12; 10(1):4. . View in PubMed

• Terrault, Norah
• Emamaullee, Juliet
• Tsukamoto, Hidekazu
• Lee, Brian
• Gonzalez, Frank
• Kohli, Rohit